Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dimitrios Koufogiannis"'
Autor:
Anastasios Sioundas, E. Papanastassiou, Dimitrios Koufogiannis, Apostolos Ballas, Kyriakos Psarrakos, K Hatziioannou
Publikováno v:
Computerized Medical Imaging and Graphics. 30:417-426
The aim of the present study was to investigate in detail the variation of the intrinsic spatial resolution across the useful field of view (UFOV) of gamma-cameras and to explore whether this variation could lead to observable effects in clinical ima
Autor:
Anastasia Fotiadu, Prodromos Hytiroglou, Eleni Vrettou, Dimitrios Koufogiannis, Valentini Tzioufa, Constantine S. Papadimitriou
Publikováno v:
Liver International. 24:268-274
Background/Aim: Oval cell proliferation is known to occur in experimental models of hepatic regeneration and carcinogenesis. Recent studies have suggested that activation of progenitor cells, representing the human counterpart of oval cells, may play
Autor:
Diamantis Chloros, Agapios Gavriilidis, Lazaros Sichletidis, Anastasios Siountas, Theodoros Konstantinidis, I. Tsiotsios, Dimitrios Koufogiannis, Kiriakos Psarrakos, Dimitrios Filippou
Publikováno v:
Archives of Environmental Health: An International Journal. 58:789-793
Lignite contains various trace-metal natural radioactive contaminants. In the Eordea Basin, the most important lignite field in Greece, the authors conducted a proportional mortality ratio (PMR) study that compared the mortality rates of individuals
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 19(2)
Objective: Recent studies have demonstrated octreotide as being potentially beneficial for the long-term management of cirrhotic portal hypertension. However, its short-term effects, requiring subcutaneous administration at least twice daily, make it
Publikováno v:
Gastroenterology. 118:A1261
Objective: Recent studies have demonstrated octreotide as being potentially beneficial for the long-term management of cirrhotic portal hypertension. However, its short-term effects, requiring subcutaneous administration at least twice daily, make it